Pharmacodynamic Study of Pembrolizumab in Patients with Recurrent Glioblastoma
The goal of this clinical research study is to learn if Keytruda (pembrolizumab) can help to control glioblastoma. The safety of this drug will also be studied.
Treatment Location: N/A
IRB Review and Approval Date: 04/28/2015
Recruitment Status: Closed
Projected Accrual: N/A
Information and next steps
For general questions about clinical trials: